Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (3690852 Ergebnisse gefunden) Es.
| Datum | Thema | |
|---|---|---|
| 20.04.26 | FreightCar America, Inc. To Release First Quarter 2026 Results On May 4, 2026 | |
| CHICAGO, April 20, 2026 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL), a diversified manufacturer of railroad freight cars, today announced that it will release its first quarter 2026 financial results on Monday, May 4, 2026, after the market close, and host a teleconference to discuss its first quarter 2026 results on the following day. [...] | ||
| 20.04.26 | Coreo Aktie: Manage-to-Core-Kurs | |
| Coreo AG setzt verstärkt auf die Aufwertung ihres Bestands. Das Unternehmen konzentriert sich dabei auf deutsche Ballungszentren. Ziel ist eine nachhaltige Wertsteigerung. Dafür nutzt Coreo ein aktives Asset Management. Fokus auf Value-Add-Objekte Die Strategie folgt einem klaren Muster. [...] | ||
| 20.04.26 | SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026 | |
| SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the first quarter of 2026 after market close on Monday, May 11, 2026. [...] | ||
| 20.04.26 | Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares | |
| NEW HAVEN, Conn., April 20, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced the closing of its previously announced underwritten public offering of 13,340,000 shares of its common stock at a public offering price of $13.00 per share, which includes 1,740,000 additional shares issued upon the exercise in full by the underwriters of their option to purchase additional shares of common stock in the public offering at the public offering price, less underwriting discounts and commissions. [...] | ||
| 20.04.26 | Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| FOSTER CITY, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective April 17, 2026, it granted stock options to purchase an aggregate of 855,000 shares of common stock to nine newly hired employees a. [...] | ||
| 20.04.26 | TWFG, Inc. To Announce First Quarter 2026 Financial Results on Thursday, May 7, 2026 | |
| TWFG, Inc. To Announce First Quarter 2026 Financial Results on Thursday, May 7, 2026. [...] | ||
| 20.04.26 | Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 | |
| SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the first quarter of 2026 after the close of trading on Monday, May 11, 2026. [...] | ||
| 20.04.26 | CarGurus To Report First Quarter 2026 Financial Results | |
| BOSTON, April 20, 2026 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited automotive shopping site in the U.S.1, announced it will issue a press release reporting financial results for the quarter ended March 31, 2026, after the close of the market on May 7, 2026.. [...] | ||
| 20.04.26 | PDF Solutions to Report First Quarter Fiscal 2026 Financial Results on May 7, 2026 | |
| SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor ecosystem, announced that it will release First quarter fiscal 2026 financial results after the market close on Thursday, May 7, 2026. [...] | ||
| 20.04.26 | Regeneron Announces Investor Conference Presentations | |
| TARRYTOWN, N.Y., April 20, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:. [...] |
